Aug
29
2010
--

In Cystic Fibrosis Patients, Vitamin D May Treat And Prevent Allergic Reaction To Mold

Originally posted in Cystic Fibrosis News From Medical News Today

Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, according to researchers from Children’s Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of Medicine and Louisiana State University School of Medicine. Results of the study, led by Jay Kolls, M.D., Ph.D…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

Aug
28
2010
--

Luminex Announces Commercial Launch Of New Cystic Fibrosis Test

Originally posted in Cystic Fibrosis News From Medical News Today

Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, announced the full commercial launch of its xTAG® Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of hours…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

Aug
17
2010
--

News From The Journal Of Clinical Investigation: Aug. 16, 2010

Originally posted in Cystic Fibrosis News From Medical News Today

PULMONARY: Can vitamin D reduce a complication of cystic fibrosis? The lungs of most individuals with cystic fibrosis are colonized by the mold Aspergillus fumigatus. In some this causes a condition known as allergic bronchopulmonary aspergillosis (ABPA), which is characterized by wheezing, lung infiltration by immune cells, and lung scarring, while others remain disease free…

Written by Cystic Fibrosis News From Medical News Today in: Nutrition / Diet |

Aug
10
2010
--

"Improving Access To Clinical Trials Act" Passes U.S. Senate In Victory For CF Advocates

Originally posted in Cystic Fibrosis News From Medical News Today

The U.S. Senate has passed the “Improving Access to Clinical Trials Act” (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations. The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits…

Written by Cystic Fibrosis News From Medical News Today in: Clinical Trials / Drug Trials |

Bookmark Us!

©Uncle & Drunken Crayfish Productions 2011 www.DrunkenCrayfish.com DrunkenCrayfish

Visit our NEW site at PocketBiker.com
PocketBiker.com Logo

 

TheBuckmaker.com Wordpress Themes | Hosting Provider, Mixed-Tape Free Music